Jacob J, Francisco LE, Chatterjee T, Liang Z, et al. An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer. Br J Cancer 2023 Feb 9. doi: 10.1038/s41416-023-02192.
PMID: 36759728